Comparing Two Steroids, Dexamethasone and Methylprednisolone, for Sacroiliac Joint Pain Treatment Using Injections

What this Trial Is About

Researchers are comparing two types of corticosteroids, dexamethasone and methylprednisolone, used in sacroiliac SI joint injections to treat SI joint pain. The study aims to evaluate and compare the effectiveness and safety of these two medications for people with diagnosed SI joint dysfunction. Participants will be randomly assigned to receive one of these treatments to better understand their impact on pain relief. Participants will be divided into two groups. One group will receive an injection of dexamethasone combined with lidocaine to one or both SI joints, and the other group will receive methylprednisolone with lidocaine in a similar manner. If pain initially improves but then returns, participants may receive a second injection with the same medication and dose. The study includes a three-month follow-up period to observe outcomes after treatment. During the study, participants will report their pain immediately after the injection to confirm SI joint pain and will be followed regularly for three months. Researchers will assess pain levels using a Numeric Pain Rating Score and monitor any side effects or safety concerns. Participants must attend all planned follow-up visits and complete outcome assessments to help compare how each medication works over time.

Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection